Navigation Links
FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents
Date:9/8/2008

BOSTON, Sept. 8 /PRNewswire/ -- FluoroPharma, Inc. announced today that Dr. David Elmaleh, FluoroPharma's founder and Chief Scientific Advisor, will report on two preclinical studies demonstrating the potential of novel Positron Emission Tomography (PET) molecular imaging agents for detection of Alzheimer's disease (AD) and prostate cancer at the World Molecular Imaging Congress, in Nice, France on September 10-13, 2008.

The first study, "Synthesis And Biodistribution Of 2-(2-[18f]Fluoroethyl)-8-Methyl-2,8-Diazaspiro[4,5]Decane-1,3,-Dione ([18f]Fluoro-RS-86), A Muscarinic Acetylcholine Receptor Agonist" describes the synthesis, tissue distribution and pharmacokinetic profile of 18F labeled RS-86, a known M1 muscarinic receptor agonist. FluoroPharma has developed a novel biomarker approach for evaluating the progression of Alzheimer's disease based on targeting acetylcholine receptors' activity in the brain. As explained by Dr. Elmaleh, "Acetylcholine receptors have become a potential therapeutic target for improving cognitive function, since the receptors' function in patients with AD is impaired due to accumulation of amyloid plaque. In conjunction with PET imaging, FluoroPharma's compound may be a novel approach to the diagnosis of AD and other neurological diseases and the evaluation of new therapeutics."

The second study, "Accumulation Of F-18 Labeled Modified Fatty Acid (CardioPET) In Prostate Tumor Cells: A Potential Sensitive Pet Tracer For Prostate Imaging" explores the potential of CardioPET, a fatty acid analog, to detect prostate cancer. CardioPET concentrates in significant amounts in human prostate tumor cells and shows potential as a highly sensitive agent for detecting prostate cancer. Prostate cancer is the most frequently diagnosed and second most lethal malignancy among men in the United States.

"These new molecular imaging approaches complement FluoroPharma's existing cardiovascular clinical programs and warrant further
'/>"/>

SOURCE FluoroPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Society of Interventional Radiology Applauds Reports Uterine Fibroid Embolization Recommendations
2. Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter
3. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
4. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
5. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
6. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
7. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
8. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
9. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
10. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
11. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... EMERYVILLE, Calif. , Nov. 25, 2014 ... nanotechnology company focused on the development of ... more accurate testing in hospital and pre-hospital ... Standards Organization (ISO) 13485:2003 certification.  The certification ... (BSI), one of the world,s leading certification ...
(Date:11/26/2014)... , Nov. 25, 2014  Breckenridge Pharmaceutical, ... a multi-product ANDA agreement with Pii (Pharmaceutics International, ... under which Breckenridge and Pii expect to develop ... of the agreement, Pii will develop, manufacture and ... distribute the products under its own label.  The ...
(Date:11/26/2014)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 3, ... Helen Torley , President and Chief Executive Officer, will ... webcast through the "Investors" section of Halozyme,s corporate website at ... for 90 days following the event. To access the live ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... Baxano, Inc. ( www.baxano.com ) today announced the closing ... funding, led by new investor CMEA Capital.   Funds were also ... and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny ... , ...
... China , June 22 /PRNewswire-Asia-FirstCall/ -- ... "Company"), a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals ... Company plans to launch its new all-natural anti-depressant ... Tablets"), a,single plant based medicine, in July ...
Cached Medicine Technology:Baxano, Inc. Announces Close of $30 Million Series C Funding 2Renhuang to Launch New All-Natural Anti-depressant and Nerve Regulation Product - Compound Schisandra Tablets 2Renhuang to Launch New All-Natural Anti-depressant and Nerve Regulation Product - Compound Schisandra Tablets 3Renhuang to Launch New All-Natural Anti-depressant and Nerve Regulation Product - Compound Schisandra Tablets 4
(Date:11/26/2014)... (PRWEB) November 26, 2014 Loffler Companies ... The Week in Imaging, an online information and news ... This is the sixth consecutive year Loffler has earned ... years. , The Elite Dealer Awards honor the best ... This year’s Elite Dealer honorees were chosen for their ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance ... organization providing the adult demographic education and access ... navigate the rough seas of applying for Medicaid. Part ... the topic of Medicaid eligibility and proper planning, while ... applying for this coverage. , Senior Planning Services ...
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... Rouge, Louisiana (PRWEB) November 26, 2014 ... neck pain relief and specialists in minimally invasive ... K. Samer Shamieh into the rapidly growing provider ... specialists. The addition coincides with the network’s ... reliable medical treatment for Louisiana residents who are ...
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2
... (BMC) New England Centenarian Study report that for ... age-related diseases (i.e. stroke, cardiovascular disease, diabetes) may ... the avoidance of disability may be a key ... in the February 11th issue of Archives of ...
... of the ovaries has been widely adopted as ... or BRCA2 mutations. A new multicenter study led ... is the first prospective examination of the impact ... were analyzed separately from BRCA1 mutation carriers. All ...
... 11 Team Health Inc.,s parent,company, Team Finance ... the fiscal year and the fourth quarter ended ... the decision to exit the anesthesia,management services business ... existing relationships within this operation and the final,phase ...
... today announced it has extended the enrollment deadline to,March ... medical plan. The new,plans will become effective on May ... can be difficult, and we,have heard retirees, requests for ... Secretary of Administration Naomi Wyatt said.,"Therefore, we are providing ...
... developed at MIT can deliver controlled drug doses to ... as a micro pharmacy. , The film could eventually ... and other diseases. It is among the first drug-delivery ... small electric field. , You can mete out what ...
... million, Five-year Grant, from New York State Department of,Health, ... Lead,Poisoned, NEW YORK, Feb. 11 The Lead ... Montefiore,(CHAM) has been named one of three State Regional ... healthcare delivery for children and,pregnant women with elevated blood ...
Cached Medicine News:Health News:Researchers at BMC find disability does not necessarily follow disease in living to old age 2Health News:Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations 2Health News:Team Finance LLC Announces Fiscal 2007 Results 2Health News:Team Finance LLC Announces Fiscal 2007 Results 3Health News:Team Finance LLC Announces Fiscal 2007 Results 4Health News:Team Finance LLC Announces Fiscal 2007 Results 5Health News:Team Finance LLC Announces Fiscal 2007 Results 6Health News:Team Finance LLC Announces Fiscal 2007 Results 7Health News:Team Finance LLC Announces Fiscal 2007 Results 8Health News:Team Finance LLC Announces Fiscal 2007 Results 9Health News:Team Finance LLC Announces Fiscal 2007 Results 10Health News:Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 2Health News:MIT develops thin-film 'micro pharmacy' 2Health News:Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: